Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Merck and NSTI Nanotech Now Accepting Abstracts for Consideration for the Merck Corporate Symposium on Targeted Delivery of siRNA

Abstract:
The Nano Science and Technology Institute (NSTI) is pleased to announce that abstracts are being accepted for the Merck Corporate Symposium: Targeted Delivery of siRNA, to be held during Nanotech 2008 in Boston, MA. The Symposium will provide an important platform for Merck to engage leading researchers in the nano tech community and create a discussion around the application of emerging nano technologies and their ability to affect targeted delivery of therapeutic siRNA molecules.

Merck and NSTI Nanotech Now Accepting Abstracts for Consideration for the Merck Corporate Symposium on Targeted Delivery of siRNA

CAMBRIDGE, MA | Posted on October 24th, 2007

Merck places a strong emphasis on innovation in all areas of drug research, development and commercialization. "Merck is pleased to partner with the NSTI in bringing this Symposium to Greater Boston, a leading region for the life sciences industry and advanced patient care," said Dr. Reid Leonard, Merck's Executive Director of Licensing and External Research. "Nanotech 2008 reflects our commitment to innovation and provides an ideal forum for the presentation of siRNA enabling technologies - an area where Merck has assumed a leadership role."

NSTI Nanotech 2008 will be held June 1-5 at the Hynes Convention Center in Boston, MA. Entering its 11th year, Nanotech 2008 is the world's largest and most comprehensive technical and business event in nanotechnology. "Merck's Corporate Symposium will be one of the highlights of next year's conference," noted Dr. Bart Romanowicz, Executive Director of the Nano Science and Technology Institute. "We are delighted that Merck, one of the largest pharmaceutical companies in the world, has partnered with Nanotech 2008 to help address their company's advanced research needs."

To participate in the Merck Corporate Symposium, please submit your abstract through the Nanotech On-Line Abstract Submission form by December 6th, 2007: http://www.nsti.org/Nanotech2008/symposia/Merck.html .

####

About Nano Science and Technology Institute (NSTI)
The Nano Science and Technology Institute (NSTI; http://www.nsti.org ) is chartered with the advancement and integration of nano and other advanced technologies through education, collaboration and research services. Nanotech 2008 is expected to attract more than 4,000 industrial, academic, business and governmental attendees from around the world.

About Merck:

Merck & Co., Inc. ( http://www.merck.com ) is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.

For more information, please click here

Contacts:
The Nano Science and Technology Institute
Jennifer Rocha, 508-357-2925

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

NUS researchers invent new test kit for quick, accurate and low-cost screening of diseases: Test results are denoted by a color change and could be further analyzed by a smartphone app, making it attractive as a point-of-care diagnostic device September 19th, 2018

Announcements

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Events/Classes

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Arrowhead Pharmaceuticals to Present at Upcoming September 2018 Conferences August 31st, 2018

Stress-free ALD from Picosun August 28th, 2018

Kavli Lectures: New vision of nanomaterial synthesis and light-fueled space travel August 8th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project